Feb 18, 2022 / 08:30AM GMT
Anish Swadi - Hikal Ltd - President, Strategy & Business Development
With me, I have Mr. Kuldeep Jain, our Chief Financial Officer, Mr. Manoj Mehrotra, our President, Pharmaceuticals business, Mr. Vimal Kulshrestha, our President, Crop Protection business, and Strategic Growth Advisors, our Investor Relations advisors.
We hope you and your family members are safe and healthy. I'm pleased to interact with all of you on our Q3 '22 Earnings Call. I hope you have gone through our earnings release, presentation, and financial results for the quarter. You can find these on the stock exchanges and on our website too. As an organization, we continue to follow all the necessary guidelines to safeguard our employees as well as ensuring that manufacturing operations are not hampered due to COVID-19 reasons. Our employees across the company are now 100% vaccinated for both doses.
I'm going to start off the call with a comment on the incident at Surat. I would at this point of time like to update you all on the Surat matter where, as you are all aware, three of our employees have been cooperating
Q3 2022 Hikal Ltd Earnings Call Transcript
Feb 18, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers